INFLIXIMAB (IFX) IN MODERATE TO SEVERE ULCERATIVE COLITIS (UC): COMPARISON BETWEEN SCHEDULED TREATMENT STRATEGY AND BRIDGE STRATEGY

被引：0
|
作者：
Sambuelli, Alicia M.
Bellicoso, Maricel I.
Goncalves, Silvina A.
Negreira, Silvia
Huernos, Sergio P.
Chavero, Paula
Carraro, Cecilia
Tirado, Pablo
Cabanne, Ana
Gil, Anibal H.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31579-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1944
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [21] Infliximab in the treatment of moderate to severe glucocorticoid dependent ulcerative colitis: A randomized methylprednisolone controlled trial
    Armuzzi, A
    Lupascu, A
    Fedeli, P
    De Pascalis, B
    Gasbarriini, G
    Gasbarrini, A
    GASTROENTEROLOGY, 2004, 126 (04) : A464 - A464
  • [22] Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis
    Druyts, Kristian Thorlund Eric
    Kanters, Steve
    Eapen, Shawn
    Mills, Edward
    GASTROENTEROLOGY, 2014, 146 (05) : S202 - S202
  • [23] Infliximab in the treatment of moderate-to-severe ulcerative colitis: Results of a large multicenter Italian survey
    Cappello, M.
    Mazza, M.
    Costantino, G.
    Fries, W.
    Privitera, A. C.
    Mastronardi, M.
    Bossa, F.
    Rispo, A.
    Castiglione, F.
    Lauria, A.
    Buccianti, N.
    Marasco, R.
    Grossi, L.
    Principi, M. B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S252 - S252
  • [24] COST-EFFECTIVENESS OF GOLIMUMAB VERSUS INFLIXIMAB AND ADALIMUMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS
    Thorlund, K.
    Druyts, E.
    Eapen, S.
    Mills, E.
    VALUE IN HEALTH, 2014, 17 (03) : A38 - A38
  • [25] TREATMENT FAILURE AND REMISSION IN MODERATE TO SEVERE ULCERATIVE COLITIS (UC) AND CROHN'S DISEASE (CD) IN EUROPE
    Achra, M.
    Karpe, K.
    Franklin, B.
    VALUE IN HEALTH, 2019, 22 : S617 - S617
  • [26] INFLIXIMAB OR CICLOSPORIN: PATIENTS' TREATMENT PREFERENCES AND THE IMPACT OF ULCERATIVE COLITIS (UC) ON THEIR LIVES
    Seagrove, A.
    Rapport, F.
    Williams, J.
    GUT, 2014, 63 : A65 - A65
  • [27] Comparison of Real World Outcomes of Adalimumab and Infliximab for Patients With Moderate or Severe Ulcerative Colitis in the United States
    Sakuraba, Atsushi
    Sandborn, William J.
    Skup, Martha
    Macaulay, Dendy
    Reichmann, William M.
    Chao, Jingdong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S772 - S772
  • [28] Induction of Remission by Infliximab and Maintenance by Azathioprine : An Effective Strategy in Moderately Severe Steroid Refractory Ulcerative Colitis
    Mahajan, Ramit
    Singh, Arshdeep
    Midha, Vandana
    Sood, Ajit
    Kaur, Kirandeep
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 182 - 182
  • [29] Is There a Role for Infliximab in the Treatment of Severe Ulcerative Colitis?: the American Experience
    Sandborn, William J.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 : S232 - S233
  • [30] Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab
    Fortuny Bauza, Marta
    Canete Pizarro, Fiorella
    Calm Salvans, Anna
    Calafat Sard, Margalida
    Domenech Morral, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 : 11 - 12
12345